IMMUNE-MEDIATED OESOPHAGITIS

This adverse event was reported 72 times

These drugs are most commonly taken by patients reporting IMMUNE-MEDIATED OESOPHAGITIS:

# Drug Count
0 PEMBROLIZUMAB 37
1 NIVOLUMAB 29
2 CARBOPLATIN 12
3 IPILIMUMAB 12
4 PEMETREXED DISODIUM 9
5 PEMETREXED 8
6 OXALIPLATIN 5
7 DEXAMETHASONE 4
8 DEXAMETHASONE 1.5 MG 4
9 LENVATINIB 4
See all common drugs associated with IMMUNE-MEDIATED OESOPHAGITIS

IMMUNE-MEDIATED OESOPHAGITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NALDEMEDINE 2 0.0012
1 TREMELIMUMAB 2 0.0005
2 PEMBROLIZUMAB 37 0.0003
3 AZILSARTAN KAMEDOXOMIL 1 0.0003
4 LEVOLEUCOVORIN INJECTION 1 0.0003
5 NIVOLUMAB 29 0.0003
6 IPILIMUMAB 12 0.0003
7 LEVOLEUCOVORIN 1 0.0003
8 AVELUMAB 1 0.0002
9 PEMETREXED DISODIUM 9 0.0002
See all drugs enriched for association with IMMUNE-MEDIATED OESOPHAGITIS